companydata.dkcompanydata.dk
Back to company

BILLEV PHARMA ApS: Financial statements 2016

CVR: 81814813

BILLEV PHARMA ApS (CVR 81814813) has filed annual accounts for 2016. In 2016, the company reported a net result of DKK 2,007,612 compared with DKK 636,436 the year before. Equity amounted to DKK 2,327,612. The solvency ratio was 50.7%.

Profit/Loss
2,007,612 kr.
Equity
2,327,612 kr.
Total Assets
4,587,394 kr.

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2016--2 mio.2.3 mio.-
2015-9.7 mio.636 t.956 t.-
2014-9.7 mio.517 t.1.5 mio.-
2013-9.4 mio.728 t.2.4 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is BILLEV PHARMA ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2016

VAN ARKENS HOLDING ApS registered as owner of BILLEV PHARMA ApSJun 29, 2016

As of June 29, 2016, VAN ARKENS HOLDING ApS is registered as an owner of BILLEV PHARMA ApS with an ownership share of 50%.

UL JENSEN HOLDING ApS registered as owner of BILLEV PHARMA ApSJun 29, 2016

As of June 29, 2016, UL JENSEN HOLDING ApS is registered as an owner of BILLEV PHARMA ApS with an ownership share of 50%.

About BILLEV PHARMA ApS

BILLEV PHARMA ApS is a Danish company of the type Anpartsselskab based in Hørsholm, founded in 1977. The company is registered under the industry Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.. The management consists of Ulrikke Lynge Jensen and Anja Wencke van Arkens. The company is owned by VAN ARKENS HOLDING ApS and UL JENSEN HOLDING ApS. The company has 15 employees. In 2026, the company reported a gross profit of DKK 38,801,270 and a net result of DKK 10,205,639 compared with DKK 6,143,854 the year before. Equity amounted to DKK 10,525,639.

Other financial years

2026202520242023202220212020201920182017201520142013